Myriad Genetics Launches the EndoPredict® Test in the United States for Patients with Breast Cancer

    NEXT STORY
    Tabula Rasa HealthCare to Present at the American Society for Clinical Pharmacology and Therapeutics Annual Meeting
    PREV STORY
    Heat Biologics Meets Efficacy Endpoint in its Phase 1b Lung Cancer Trial to Progress to Phase 2
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Mustang Bio Appoints Martina A. Sersch, M.D., Ph.D., as Chief Medical Officer

    NEW YORK, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), ...

    author_avatar
    NASDAQ Market News

    Biocartis Group NV: Biocartis and Kite Sign Agreement for Development of Assays supporting Kite’s Therapies

    author_avatar
    NASDAQ Market News

    AngioDynamics to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference

    ALBANY, N.Y., Sept. 13, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of ...

    author_avatar
    NASDAQ Market News